The PwC M&A team is pleased to announce the successful sale of disapo.de Apotheke B.V. (“Disapo”) from Douglas Service GmbH (“DOUGLAS Group”) to MYA Health B.V. (“MYA”). Disapo is a well-established, officially licensed online pharmacy based in the Netherlands that sells prescription (Rx) and nonprescription (OTC) pharmaceuticals as well as a wide range of cosmetics and dietary supplements. PwC M&A conducted a structured, international sales process and supported the DOUGLAS Group in preparing necessary carve-out activities.
The DOUGLAS Group had initially acquired Disapo in 2022 as part of its former strategy to enter the pharmacy market and converge beauty and health. With its new growth strategy “Let it Bloom”, the DOUGLAS Group decided to fully shift the focus on its core premium beauty business across its stores and online shops. Hence, the DOUGLAS Group evaluated various strategic options and found a strategic investor with MYA. The new owner will continue the operations of Disapo and intends to increase the Rx market share.
The share purchase agreement was signed and closed in July 2024.
Disapo is an online pharmacy based in the Netherlands selling prescription (Rx) and nonprescription (OTC) pharmaceuticals as well as dietary supplements and milk powder articles. The Company’s geographical focus lies on the German (B2C) and the Chinese (B2C & B2B) market. It operates a large logistics center in the Netherlands and distributes its products via various sales channels including own German and Chinese webshops.
The DOUGLAS Group is the number one omnichannel premium beauty retailer in Europe offering its assortment online and in around 1,860 stores. Headquartered in Düsseldorf with a pan-European footprint, the DOUGLAS Group focuses on the growing and resilient premium beauty business offering a comprehensive and curated assortment of fragrances, cosmetics, skin care and hair care products as well as accessories and in-store beauty services.
MYA Health, based in Amsterdam, operates a mobile app offering services around prescriptions and prescription medication. The company was founded in 2021 by Christian-Alexander Vry and Dr. Daniel Lewinski and is backed by a number of investors, including Fiege Logistics. The mobile app is an all-in-one application for medication, from prescription procurement to delivery and intake, and the first of its kind on the German market.
The global PricewaterhouseCoopers network is a worldwide association of independent auditing and consulting companies which together employ more than 364,000 people in 151 countries. Our global network comprises over 2,900 M&A professionals all over the world, realising approx. 400 successful transactions per year. We specialise in a wide range of independent M&A services including advice on acquisitions and disposals, mergers, public takeovers, privatisations as well as structured financing.
PwC M&A Germany acted as exclusive financial advisor to the DOUGLAS Group on this transaction. The transaction was led by Alexander von Friesen (Partner) and supported by Hannes Stötefalke (Senior Manager), Julian Fischer (Senior Associate) and Lucas Busch (Senior Associate).
Dr. Alexander von Friesen
Partner, Corporate Finance | M&A Healthcare & Consumer, PwC Germany
Tel: +49 151 11714398